Overall, our findings of increased glycogenosis and accelerated tumorigenesis in diabetic ChREBP-KO compared to WT mice indicate that ChREBP acts as a tumor suppressor rather than a pro-oncogenic mediator in diabetes-induced nephrocarcinogenesis. Here, MLXIPL is linked to diabetes mellitus.